Peer-Reviewed Publication
Aesthetic Plast Surg2026July 8, 2026Journal Article
Therapeutic Effect of Niclosamide versus Triamcinolone on Rabbit Ear Model of Hypertrophic Scar.
Duaa Nidhal Ghazy1, Ahmed Rahmah Abu-Raghif2, Amer Oleiwi Tuama3, Furqan Mohammed Al-Asady4, Dalia Abdulzahra Al-Saray5, Dhulfiqar Ali Abed6, Saba Naseer Abbas7, Hayder Ridha-Salman8
1College of Dentistry, Al-Farahidi University, Baghdad, Iraq.
2Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq.
3Department of Dermatology, Al-Qasim General Hospital, Babylon Health Directorate, Ministry of Health Iraq, Hillah, Babylon, Iraq.
4College of Pharmacy, University of Hilla, Hillah, Babylon, 51001, Iraq.
5Department of Pharmacology, College of Dentistry, University of Babylon, Hillah, Babylon, Iraq.
6College of Pharmacy, Al-Mustaqbal University, Hillah, Babylon, 51001, Iraq.
7Department of Pharmacology and Toxicology, College of Pharmacy, Al-Esraa University, Baghdad, Iraq.
8College of Pharmacy, Al-Mustaqbal University, Hillah, Babylon, 51001, Iraq. hayder80.ridha@gmail.com.
Abstract
BACKGROUND: Hypertrophic scar is a pathological condition stemming from an aberrant wound healing response, marked by excessive collagen deposition and fibroblast proliferation. Triamcinolone acetonide, a corticosteroid drug, has long been regarded as the gold standard for the non-surgical treatment of hypertrophic scars. Niclosamide, a repurposed anti-parasitic drug, has gained growing interest f…
Create a free account to keep reading
Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.
Want unlimited research access? See Pro plans